| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242564 | Respiratory Medicine | 2012 | 10 Pages |
Abstract
The evidence suggests a beneficial effect of dual therapy in IPAH and SSc-PAH, particularly those who are deteriorating on monotherapy. Research should focus on subsets of patients to identify the optimal timing and combination of dual therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Sindhu R. Johnson, Sarah K. Brode, Lisa M. Mielniczuk, John T. Granton,